Keywords: gsk, malaria, vacc, enters, ph, iii, testing

GSK's malaria vacc enters Ph III testing

Article | 05 June 2009

Print This

A Phase III trial of the most clinically-advanced malaria vaccine candidate has been initiated at sites in the Bagamoyo Research ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in